SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Patience here will pay out in truckloads.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DaubersUP Member Profile
 
Followed By 53
Posts 4,928
Boards Moderated 0
Alias Born 12/07/11
160x600 placeholder
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 9/22/2017 6:02:17 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 9/11/2017 12:47:10 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/11/2017 6:04:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/11/2017 6:04:37 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/6/2017 6:27:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/6/2017 6:24:45 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/8/2017 4:18:08 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 8/8/2017 4:17:33 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 8/8/2017 4:17:00 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 8/8/2017 4:16:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/13/2017 4:04:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/7/2017 4:19:05 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2017 4:09:09 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 4/28/2017 12:50:45 PM
Bahamas Development Corp. (OTC Pink: BDCI) $2.4 Million in Sales and 10% Quarterly Growth – Issues Guidance "InvestorsHub NewsWire" - 4/17/2017 7:03:27 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/31/2017 4:25:24 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 3/29/2017 4:13:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/27/2017 11:29:27 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/16/2017 7:01:38 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/9/2017 4:04:17 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2017 9:39:24 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/4/2017 3:58:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/15/2016 6:25:29 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 6:06:41 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 10/28/2016 5:02:25 PM
DaubersUP   Friday, 10/06/17 06:55:58 AM
Re: sox040713 post# 199208
Post # of 200848 
Patience here will pay out in truckloads. I am very confident in that. I wish I could see into the future and know which route will be taken, but I am not a psychic. The next step as you say, wait for 3 phase 2 trials to conclude and for the data.

We've had plenty of sound bites from IPIX that partnership is their priority, that BP knows the value of their pipeline and that BP knows IPIX knows the true value, and we do have CDAs in place with several BPs and that IPIX is the farthest they have ever been in our history in regards to BP and negotiations/talks. All of the above is documented by IPIX.

Taking these promising drugs thru preclinical to now (for some) thru phase 2b is a tip of the cap for me. Not many biotechs can get to this point with one drug and one indication. We have 3 and 1 of those drugs has 3 indications moving thru phase 2 currently.

No one can take that away from us Sox. I will buy 5000 more shares today and again lock it up. That 5000 will go to my niece and most likely pay for her college in 20 years.

Cheers


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist